Richard E. Pratt
-
- Renin-Angiotensin System Studies 48
-
- Hormonal Regulation and Hypertension 33
- Genetics top 0.2%
- Mesenchymal stem cell research 11
- Molecular Biology top 0.5%
- Receptor Mechanisms and Signaling 36
- Congenital heart defects research 14
- Pluripotent Stem Cells Research 11
- RNA Interference and Gene Delivery 10
- Transplantation top 2%
-
- Tissue Engineering and Regenerative Medicine 16
- Co-authors
- Victor J. DzauLunan ZhangGary H. GibbonsV J DzauAllen J. NaftilanLutz HeinBrian K. KobilkaLuis G. Melo
- Partner nations
- United StatesJapanCanada
In The Last Decade
Richard E. Pratt
168 papers receiving 13.1k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Cardiology and Cardiovascular Medicine 6.3k
- Endocrinology, Diabetes and Metabolism 3.1k
- Genetics 1.9k
- Molecular Biology 6.6k
- Transplantation 204
Countries citing papers authored by Richard E. Pratt
This map shows the geographic impact of Richard E. Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Pratt more than expected).
Fields of papers citing papers by Richard E. Pratt
This network shows the impact of papers produced by Richard E. Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Pratt. The network helps show where Richard E. Pratt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard E. Pratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 16 | |
| 6 | 2015 | 13 | |
| 7 | 2015 | 31 | |
| 8 | Abstract 15731: Hypoxia and Akt Induced Stem Cell Factor Exerts Cardioprotective Effects via Specific Binding to the Insulin-Like Growth Factor-1 Receptor | 2014 | 1 |
| 9 | 2008 | 103 | |
| 10 | 2007 | 176 | |
| 11 | 2003 | 19 | |
| 12 | 2002 | 133 | |
| 13 | 1997 | 197 | |
| 14 | Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in micebreakdown → | 1995 | 606 |
| 15 | 1995 | 22 | |
| 16 | 1994 | 33 | |
| 17 | 1991 | 108 | |
| 18 | 1991 | 2 | |
| 19 | Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.breakdown → | 1989 | 543 |
| 20 | 1988 | 1 |
About Richard E. Pratt
Richard E. Pratt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology, Genetics and Immunology and Allergy, having authored 169 papers that have together received 13.4k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (48 papers), Receptor Mechanisms and Signaling (36 papers), Hormonal Regulation and Hypertension (33 papers), Tissue Engineering and Regenerative Medicine (16 papers), Congenital heart defects research (14 papers), Pluripotent Stem Cells Research (11 papers), Mesenchymal stem cell research (11 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.3k citations), Endocrinology, Diabetes and Metabolism (3.1k citations), Genetics (1.9k citations), Molecular Biology (6.6k citations) and Transplantation (204 citations). Richard E. Pratt has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Victor J. Dzau, Lunan Zhang, Gary H. Gibbons, V J Dzau, Allen J. Naftilan, Lutz Hein, Brian K. Kobilka, Luis G. Melo, Masatsugu Horiuchi and Massimiliano Gnecchi. Their work appears in journals such as Circulation, Hypertension, Journal of Biological Chemistry, Journal of Clinical Investigation and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.